BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 8710868)

  • 1. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.
    Werner H; Karnieli E; Rauscher FJ; LeRoith D
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8318-23. PubMed ID: 8710868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
    Idelman G; Glaser T; Roberts CT; Werner H
    J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.
    Rubinstein M; Idelman G; Plymate SR; Narla G; Friedman SL; Werner H
    Endocrinology; 2004 Aug; 145(8):3769-77. PubMed ID: 15131018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53-dependent manner.
    Attias Z; Werner H; Vaisman N
    Endocr Relat Cancer; 2006 Jun; 13(2):571-81. PubMed ID: 16728583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.
    Maor SB; Abramovitch S; Erdos MR; Brody LC; Werner H
    Mol Genet Metab; 2000 Feb; 69(2):130-6. PubMed ID: 10720440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
    Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
    Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene.
    Abramovitch S; Werner H
    Horm Metab Res; 2003; 35(11-12):758-62. PubMed ID: 14710355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.
    Werner H; Re GG; Drummond IA; Sukhatme VP; Rauscher FJ; Sens DA; Garvin AJ; LeRoith D; Roberts CT
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5828-32. PubMed ID: 8390684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
    Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
    J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1.
    Ohlsson C; Kley N; Werner H; LeRoith D
    Endocrinology; 1998 Mar; 139(3):1101-7. PubMed ID: 9492043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.
    Werner H; Shen-Orr Z; Rauscher FJ; Morris JF; Roberts CT; LeRoith D
    Mol Cell Biol; 1995 Jul; 15(7):3516-22. PubMed ID: 7791758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cells.
    Zhang L; Zhan Q; Zhan S; Kashanchi F; Fornace AJ; Seth P; Helman LJ
    DNA Cell Biol; 1998 Feb; 17(2):125-31. PubMed ID: 9502429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.
    Schwartzenberg-Bar-Yoseph F; Armoni M; Karnieli E
    Cancer Res; 2004 Apr; 64(7):2627-33. PubMed ID: 15059920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
    Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
    Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer.
    Werner H; Shalita-Chesner M; Abramovitch S; Idelman G; Shaharabani-Gargir L; Glaser T
    Mol Genet Metab; 2000; 71(1-2):315-20. PubMed ID: 11001824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.
    Zhang L; Kashanchi F; Zhan Q; Zhan S; Brady JN; Fornace AJ; Seth P; Helman LJ
    Cancer Res; 1996 Mar; 56(6):1367-73. PubMed ID: 8640827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist effect of insulin-like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL.
    Toms SA; Hercbergs A; Liu J; Kondo S; Haqqi T; Casey G; Iwasaki K; Barnett GH; Barna BP
    J Neurosurg; 1998 May; 88(5):884-9. PubMed ID: 9576258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y; Tan M; Gosink M; Wang KK; Sun Y
    Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
    Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
    Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.